Malmö, Sweden – July 8, 2025 – Acarix, a global pioneer in AI-driven and acoustics-based cardiac diagnostics, is proud to announce its first order in the Middle East and North Africa (MENA) region. Valued at 1.35M SEK, this order from a leading regional distributor represents a significant step in Acarix’s international expansion strategy.
This milestone marks Acarix’s official entry into one of the world’s most dynamic healthcare markets, underscoring the growing global demand for its innovative diagnostic solutions aimed at improving early detection of coronary artery disease.
Aamir Mahmood, CEO of Acarix, commented:
“We are thrilled to enter the MENA region with this strategic order. Expanding into new markets is central to our mission of making advanced cardiac diagnostics more accessible worldwide. This order not only demonstrates confidence in our technology but also lays the foundation for long-term partnerships that can transform patient care in the region. While this is a key milestone for Acarix, we remain deeply focused on the U.S. market, where demand continues to grow.”
Acarix’s expansion into the MENA region reflects its commitment to global health equity by delivering faster, non-invasive diagnostic tools that empower healthcare providers with advanced technology—supporting more accurate clinical decisions, improving patient outcomes, and expanding access to quality cardiovascular care across diverse populations